Package Leaflet: Information for the User
Olmesartan/Amlodipine Normon 40 mg/10 mg film-coated tablets EFG
olmesartan medoxomil / amlodipine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
Olmesartan/Amlodipine Normon contains two active substances called olmesartan medoxomil and amlodipine (as amlodipine besylate). Both substances help to control high blood pressure.
The action of both substances contributes to preventing the narrowing of blood vessels, so they relax and blood pressure decreases.
Olmesartan /Amlodipine Normon is used to treat high blood pressure in patients whose blood pressure is not adequately controlled with olmesartan or amlodipine alone.
Do not take Olmesartan /Amlodipino Normon
If you think you may be allergic, inform your doctor before taking Olmesartan /Amlodipino Normon.
Warnings and precautions
Consult your doctor or pharmacist before starting to use Olmesartan /Amlodipino Normon.
Consult your doctor if you experience abdominal pain, nausea, vomiting, or diarrhea after taking Olmesartan/Amlodipino Normon. Your doctor will decide whether to continue treatment. Do not stop taking Olmesartan/Amlodipino Normon on your own.
Tell your doctorif you are taking any of the following medicines used to treat high blood pressure (hypertension):
Your doctor may need to monitor your kidney function, blood pressure, and blood electrolyte levels (e.g., potassium) at regular intervals.
See also the information under the heading “Do not take Olmesartan /Amlodipino Normon”.
Tell your doctorif you have any of the following health problems:
Contact your doctor if you experience severe, persistent diarrhea that causes significant weight loss. Your doctor will assess your symptoms and decide how to proceed with your blood pressure treatment.
As with any other medicine that lowers blood pressure, an excessive drop in blood pressure in patients with impaired blood flow to the heart or brain may cause a heart attack or stroke. Therefore, your doctor will carefully monitor your blood pressure.
You must inform your doctor if you are pregnant or think you might be. Olmesartan /Amlodipino Normon is not recommended during the first trimester of pregnancy, and it must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if taken during this period (see section “Pregnancy and breast-feeding”).
Children and adolescents (under 18 years)
Olmesartan /Amlodipino Normon is not recommended for children and adolescents under 18 years.
Using Olmesartan /Amlodipino Normon with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including:
Your doctor may need to adjust your dose and/or take other precautions:
If you are taking an angiotensin-converting enzyme inhibitor (ACE inhibitor) or aliskiren (see also the information under the headings “Do not take Olmesartan /Amlodipino Normon” and “Warnings and precautions”).
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Taking Olmesartan /Amlodipino Normon with food and drinks
Olmesartan /Amlodipino Normon can be taken with or without food. Take the tablets with a little liquid (such as a glass of water). If possible, take your daily dose at the same time each day, for example, at breakfast time.
People taking Olmesartan /Amlodipino Normon should not consume grapefruit or grapefruit juice. This is because grapefruit and grapefruit juice can lead to an increase in the levels of the active ingredient amlodipine in the blood, which may cause an unpredictable increase in the blood pressure-lowering effect of Olmesartan /Amlodipino Normon.
Elderly patients
If you are over 65 years old, your doctor will regularly check your blood pressure whenever your dose is increased, to make sure it does not drop too much.
Black patients
As with other similar medicines, the blood pressure-lowering effect of Olmesartan /Amlodipino Normon is somewhat smaller in black patients.
Pregnancy and breast-feeding
Pregnancy
You must inform your doctor if you are pregnant or think you might be.
Your doctor will advise you to stop taking Olmesartan /Amlodipino Normon before you become pregnant or as soon as you know you are pregnant, and will advise you to take another medicine instead of Olmesartan /Amlodipino Normon. Olmesartan /Amlodipino Normon is not recommended during the first trimester of pregnancy, and it must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if taken during this period.
If you become pregnant while taking Olmesartan /Amlodipino Normon, inform your doctor immediately.
Breast-feeding
Amlodipine has been shown to pass into breast milk in small amounts.
Tell your doctor if you are breast-feeding or about to start breast-feeding. Olmesartan /Amlodipino Normon is not recommended for breast-feeding mothers, and your doctor may choose another treatment if you wish to breast-feed, especially if your baby is newborn or premature.
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
During treatment for high blood pressure, you may feel drowsy, feel sick, or dizzy, or have a headache. If this happens, do not drive or use machines until the symptoms have gone away. Consult your doctor.
Olmesartan/Amlodipine Normon contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is, essentially, “sodium-free”.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
The recommended dose of Olmesartan /Amlodipine Normon is one tablet per day.
The tablets can be taken with or without food. Take the tablets with a little liquid (such as a glass of water). Do not chew the tablet. Do not take Olmesartan /Amlodipino Normon with grapefruit juice.
If possible, take your daily dose at the same time each day, for example, at breakfast time.
If you take more Olmesartan /Amlodipino Normon than you should
If you take more tablets than you should, you will probably experience a drop in blood pressure, accompanied by symptoms such as dizziness, and rapid or slow heart rate.
If you take more tablets than you should or a child accidentally ingests some tablets, contact your doctor or go to the nearest emergency center immediately and take the medicine pack or this leaflet with you.
Excess fluid may accumulate in the lungs (pulmonary edema) causing difficulty breathing, which can develop up to 24-48 hours after ingestion.
In case of overdose or accidental ingestion, consult the Toxicology Information Service. Telephone 91 562 04 20.
If you forget to take Olmesartan /Amlodipino Normon
If you forget to take a dose, take your usual dose the next day. Do nottake a double dose to make up for forgotten doses.
If you stop taking Olmesartan /Amlodipino Normon
It is important to continue taking Olmesartan /Amlodipino Normon unless your doctor tells you to stop.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. If they occur, they are often mild and do not require interruption of treatment.
The following adverse effects may be serious:
Unknown frequency: if you experience yellowing of the whites of the eyes, dark urine, skin itching, even if you started treatment with Olmesartán Normon a long time ago, contact your doctor immediatelywho will evaluate your symptoms and decide how to continue with blood pressure treatment.
During treatment with Olmesartan/Amlodipino Normon, allergic reactions can occur, which can affect the whole body, with inflammation of the face, mouth and/or larynx (vocal cords), along with itching and skin rash. If this happens to you, stop taking Olmesartan/Amlodipino Normon and consult your doctor immediately.
Olmesartan/Amlodipino Normon may cause a marked decrease in blood pressure, in susceptible patients, or as a result of an allergic reaction. This can cause fainting or severe dizziness. If this happens to you, stop taking Olmesartan/Amlodipino Normon, consult your doctor immediately, and remain lying down in a horizontal position.
Other possible adverse effects with Olmesartan/Amlodipino Normon:
Frequent (may affect up to 1 in 10 people):
Dizziness; headache; swelling of the ankles, feet, legs, hands, or arms; fatigue.
Uncommon (may affect up to 1 in 100 people):
Dizziness when standing up; lack of energy; tingling or numbness of the hands or feet; vertigo; noticing heartbeats; rapid heartbeat; low blood pressure with symptoms such as dizziness, dizziness; difficulty breathing; cough; nausea; vomiting; indigestion; diarrhea; constipation; dry mouth; pain in the upper abdomen; skin rash; cramps; pain in the arms and legs; back pain; feeling of urgency to urinate; sexual inactivity; inability to have or maintain an erection; weakness.
Some changes in the results of certain blood tests have also been observed:
Increased, as well as decreased levels of potassium in the blood, increased levels of creatinine in the blood, increased levels of uric acid, increased values of liver function tests (gamma glutamyl transferase levels).
Rare (may affect up to 1 in 1,000 people):
Hypersensitivity to the medicine; fainting; flushing and feeling of heat in the face; red hives with itching (urticaria); facial inflammation. Intestinal angioedema: swelling in the intestine that presents symptoms such as abdominal pain, nausea, vomiting, and diarrhea.
Adverse effects reported with the use of olmesartan medoxomil or amlodipine alone, but not with Olmesartan/Amlodipino Normon, or with a higher frequency:
Olmesartan
Frequent (may affect up to 1 in 10 people):
Bronchitis; sore throat; nasal congestion and secretion; cough; abdominal pain; viral gastroenteritis; diarrhea; indigestion; nausea; pain in the joints and bones; back pain; blood in the urine; urinary tract infection; chest pain; flu-like symptoms; pain. Changes in the results of blood tests, such as increased levels of a type of fat (hypertriglyceridemia); increased uric acid and urea in the blood, and increased values of liver and muscle function tests.
Uncommon (may affect up to 1 in 100 people):
Reduction in the number of a type of blood cells called platelets, which can cause easy bruising or prolonged bleeding time; rapid allergic reactions, which can affect the whole body and cause respiratory problems, as well as a rapid drop in blood pressure, which can even cause fainting (anaphylactic reactions); angina (chest pain or discomfort known as angina pectoris); itching; skin rash; allergic skin rash; urticaria; facial swelling; muscle pain; discomfort.
Rare (may affect up to 1 in 1,000 people):
Inflammation of the face, mouth, and/or larynx (vocal cords); acute kidney failure and kidney failure; lethargy.
Amlodipino
Very frequent (may affect more than 1 in 10 people):
Edema (fluid retention).
Frequent (may affect up to 1 in 10 people):
Abdominal pain; nausea; swelling of the ankles; feeling of sleep; flushing and feeling of heat in the face, visual disturbances (including double vision and blurred vision), noticing heartbeats, diarrhea, constipation, indigestion, cramps, weakness, difficulty breathing.
Uncommon (may affect up to 1 in 100 people):
Difficulty sleeping; sleep disorders; mood changes including anxiety; depression; irritability; tremor; taste disturbances; fainting; ringing in the ears (tinnitus); worsening of angina pectoris (chest pain or discomfort); irregular heartbeat; nasal secretion or congestion; hair loss; purple spots or spots on the skin due to small hemorrhages (purpura); skin discoloration; excessive sweating; skin rash; itching; red hives with itching (urticaria); joint or muscle pain; urination problems; need to urinate at night; increased need to urinate, increased breast size in men, chest pain; pain; feeling of discomfort; weight gain or loss.
Rare (may affect up to 1 in 1,000 people):
Confusion.
Very rare (may affect up to 1 in 10,000 people):
Reduction in the number of white blood cells, which could increase the risk of infections; reduction in the number of a type of blood cells called platelets, which could lead to bruising and prolonged bleeding time; increased glucose in the blood; increased muscle tension or increased resistance to passive movement (hypertonia); tingling or numbness of the hands or feet; heart attack; inflammation of blood vessels; inflammation of the liver or pancreas; inflammation of the stomach wall; gum thickening; elevated liver enzymes; yellowing of the skin and eyes; increased sensitivity of the skin to light; allergic reactions, itching, rash, inflammation of the face, mouth, and/or larynx (vocal cords), along with itching and rash, severe skin reactions, including intense skin rash, urticaria, redness of the body skin, severe itching, blisters, peeling, and skin inflammation, inflammation of the mucous membranes (Stevens-Johnson syndrome, toxic epidermal necrolysis), or other sometimes very severe allergic reactions.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging and on the blister pack (after "CAD"). The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be thrown away through the sewage system or in the trash. Deposit the packaging and medicines that you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines that you no longer need. This way, you will help protect the environment.
Composition of Olmesartan/Amlodipino Normon
The active ingredients are:
Olmesartan/Amlodipino Normon 40 mg/10 mg: each film-coated tablet contains 40 mg of olmesartan medoxomil and 10 mg of amlodipine (as amlodipine besylate).
The other components (excipients) are: pregelatinized corn starch, microcrystalline cellulose, croscarmellose, anhydrous colloidal silica, magnesium stearate, Opadry II white 85F18422 (contains: poly(vinyl alcohol), titanium dioxide (E-171), macrogol 4000, and talc), and red iron oxide (E-172).
Appearance of the product and package contents
Olmesartan/Amlodipino Normon 40 mg/10 mg is presented in the form of film-coated tablets, reddish in color, round, biconvex, and with the inscription 410 on one face.
Olmesartan/Amlodipino Normon film-coated tablets are presented in a package of 28 tablets.
Marketing authorization holder and manufacturer
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos – Madrid (SPAIN)
Date of the last revision of this leaflet: February 2025
Other sources of information
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.
The average price of OLMESARTAN/AMLODIPINE NORMON 40 mg/10 mg FILM-COATED TABLETS in October, 2025 is around 21.43 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.